What’s new? Recently returned COO Ivar Milligan muses on the team workings that make Consilium the success it is.
By Ivar Milligan, Chief Operating Officer
I’m amazed (but not surprised) at the developments and growth that have occurred in the couple of years that I was away from Consilium; the demand for Consilium’s services continues to increase and the team has grown in scale and capability to provide our excellent service to new and long-served clients. This growth is the reason for my new role and one of my areas of focus is to look to develop the team further by bringing in some of the most talented communicators from financial PR, healthcare and beyond. One of our strengths is the variety in backgrounds and experiences that our team has, and assembling advisory teams for clients to make the most of these. Despite this growth, the company’s culture, thanks to the firm being independent, has been able to retain its agility, enabling the management team to respond quickly to both clients’ and employees’ needs in a time when this is ever more important.
It is unsurprising that Consilium’s way of working has changed dramatically over the past 12 months and it is evident that the exposed strength of this team is its willingness to support and care for each other. The push to enable remote socialising and the opportunity to discuss what really matters to individuals on a daily basis has brought pastoral care to the fore and it’s refreshing to see that the relationships developed in the office, especially with new joiners, can be replicated through time on the phone or a walk through a London park. A noticeable development in the past year has been the awareness of needing time away from screens and desks; enabling a proper break in the middle of the day which is enforced and kept protected by all staff between 12:30-1:30 pm daily, and a clear cut off to routine calls and emails at 6:00 pm whilst invigorating our focus on work yet still allowing our team to respond to the urgent needs of our clients out of hours.
Our internal mentoring and training continues apace and it's gratifying to see that reflected in recent promotions and those being worked towards. It will be interesting to see how this team cohesion is affected by our return to the office; I wouldn’t be surprised if it catalyses a surge in further successes as ways of working ease back to normality. We all look forward to exploiting the best of home and office working, and to spending more time with our clients; in person.
Get the latest company updates from Consilium:
Movers and Shakers
See the latest City movers and shakers
Movers and Shakers
- OncoDNA appointed Bernard Courtieu as CEO
- SparingVision appointed Daniel C. Chung as CMO
- QuantumMDx appointed Diran Guiliguian as CCO
- Abingdon Health appointed Melanie Ross as CFO
- Sensyne Health appointed Hina Zaman as Managing Director of its Healthcare Division and Martin Gouldstone as CBO of its Life Science Division
- CMR Surgical appointed Catherine Moukheibir as Non-Executive Director
- Moderna appointed Corinne Le Goff as CCO
- Eli Lilly appointed Anat Ashkenazi as CFO
- Amylyx Pharmaceuticals appointed James Frates as CFO
- Innocoll appointed Louis Pascarella as CEO
- Valneva appointed Perry Celentano as interim COO
- eFFECTOR Therapeutics appointed Mike Byrnes as CFO
- BiondVax Pharmaceuticals appointed Amir Reichman as CEO
- Avrobio appointed Diana Escolar as CMO
- Blink Science appointed Eric Doherty as President
- Viridian Therapeutics appointed Jonathan Violin as President and CEO
- NexImmune appointed Robert Knight as CMO
- Chiasma appointed John Doyle as CFO
- Applied Molecular Transport appointed Douglas Rich as CTO
- Imara appointed Kenneth Attie as Senior Vice President and CMO
- Alector appointed Shehnaaz Suliman as interim CBO
- Faze Medicines appointed Philip Vickers as CEO
- Roivant appointed Matt Gline as CEO
- Neurophth Biotechnology appointed Qiutang Li as CSO
- Butterfly Netowork appointed Todd Fruchterman as President and CEO
- MedPharm appointed Jon Lenn as CSO
- KSQ Therapeutics appointed Qasim Rizvi as CEO
- Connect Biopharma appointed Selwyn Ho as CBO
- ViaCyte appointed Michael Yang as President and CEO
- Cognito Therapeutics appointed Mark Day as CBO
- MOMA Therapeutics appointed Asit Parikh as President and CEO
- Actimed Therapeutics appointed Frank Misselwitz as CMO
- Novo Nordisk appointed Marcus Schindler as CSO and Executive Vice President for early R&D
- Worldwide Clinical Trials appointed Brian Tuttle as CFO
- Catamaran Bio has appointed Alvin Shih as CEO
- Merck & Co appointed Robert Davies as CEO
- Tissium appointed Hunt Henrie as CBO
- CRISPR Therapeutics appointed Philippe Drouet as CCO
- OncoNano Medicine appointed Martin Discoll as CEO
- Quanticate appointed Lee Patterson as COO
- Trevi Therapeutics appointed William Forbes as CDO
- Cervance appointed Carrie Ann Cook as CBO
- OncoSec appointed Brian Leuthner as COO
- Arcellx Inc. appointed Rami Elghandour as Chairman and CEO
- Avidity Biosciences Inc. appointed Michael Flanagan as CTO
- Egetis Therapeutics AB appointed Peder Sven Walberg as CMO and Director
- Omeros Corp. appointed Nadia Dac as CCO
- Papa & Barkley Essentials LLC appointed Evelyn Wang as CEO
- SynAct Pharma AB appointed Thomas Boesen as COO
- Evolve Biologics, Inc. appointed James V. Caggiano as CEO
- Ironwood Pharmaceuticals appointed Tom McCourt as interim CEO
- Oasmia Pharmaceutical AB appointed Dr. Heidi B. Ramstad as CMO
Fundraising highlights
Highlighted fundraising activity this month
Fundraising highlights
Company Name |
Amount Raised |
Type of Fundraise |
Country |
Date |
Public company financings |
||||
Faron Pharmaceuticals |
€15 million |
Private placement |
Finland |
12-Feb-21 |
Sana Biotechnology |
$675.6 million |
IPO |
US |
9-Feb-21 |
Argenx S.E. |
$1 billion |
Follow-on |
Netherlands |
3-Feb-21 |
MaxCyte |
$55 million |
Crossover |
US |
2-Feb-21 |
CureVac N.V. |
$450 million |
Follow-on |
Germany |
28-Jan-21 |
Sensei Biotherapeutics Inc. |
$30 million |
Undisclosed |
US |
12-Jan-21 |
Cullinan Oncology LLC |
$287.4 million |
IPO |
US |
12-Jan-21 |
Private company Financings |
||||
Rubix LS |
$1.3 million |
Seed |
US |
10-Feb-21 |
Pan Cancer TBV |
Undisclosed |
Seed |
Netherlands |
10-Feb-21 |
Anticancer Bioscience |
£9.8 million |
Undisclosed |
China |
10-Feb-21 |
Drug Farm |
$56 million |
Undisclosed |
US/China |
10-Feb-21 |
Inivata |
$35 million |
Series C |
UK |
4-Feb-21 |
Reverie Labs |
$25 million |
Series A |
US |
3-Feb-21 |
SpectraWave |
$13.2 million |
Series A-2 |
US |
3-Feb-21 |
Cellino |
$16 million |
Seed |
US |
1-Feb-21 |
Parse Biotechnologies Inc. |
$7 million |
Series A |
US |
28-Jan-21 |
Enthera Pharmaceuticals |
$42.5 million |
Series A |
Italy |
28-Jan-21 |
Ukko Inc. |
$40 million |
Series B |
Israel |
28-Jan-21 |
Encodia |
$75 million |
Series C |
US |
28-Jan-21 |
Design Therapeutics |
$125 million |
Series B |
US |
28-Jan-21 |
TScan Therapeutics |
$100 million |
Series C |
US |
25-Jan-21 |
reMYND NV |
$28.9 million |
Series B |
Belgium |
21-Jan-21 |
Ikaxa Ltd. |
$54.1 million |
Undisclosed |
UK |
20-Jan-21 |
Verve Therapeutics |
$94 million |
Series B |
US |
19-Jan-21 |
NewAmsterdam Pharma |
$196 million |
Series A |
Netherlands |
15-Jan-21 |
IO Biotech |
$127 million |
Series B |
Denmark |
14-Jan-21 |
Delfi Diagnostics |
$100 million |
Series A |
US |
13-Jan-21 |
Valo Health LLC |
$190 million |
Series B |
US |
12-Jan-21 |
Visen Pharmaceuticals |
$150 million |
Series B |
China |
12-Jan-21 |
NuProbe Inc. |
$42 million |
Undisclosed |
US/China |
12-Jan-21 |
EQRx |
$500 million |
Series B |
US |
12-Jan-21 |
Scorpion Therapeutics Inc. |
$162 million |
Series B |
US |
8-Jan-21 |
Analyst directory
View our Analyst Directory
Analyst directory
Bank |
Analyst |
ABG Sundal Collier |
Morten Larsen, Daniel Thorsson |
ABN AMRO |
Mark van der Geest, Rene Verhoeff |
Alm. Brand Markets |
Michael Friis Jørgensen |
AlphaValue |
Armelle Moulin, Marion Scherzinger |
Banco de Sabadell, S.A. |
Javier Esteban |
Banco Espirito Santo de Investimento |
Luis Navia |
Bank am Bellevue |
Bruno Eschli, Stephen Leventhal |
Bankhaus Lampe KG |
Heiko Feber, Frank Neumann |
Bank Vontobel AG |
Carla Baenziger |
Barclays |
Hassan Al-Wakeel, Blanka Porkolab, Emily Field, Jameel Bakhsh, Brian Balchin, Peter Lawson |
Berenberg Bank |
Scott Bardo, Luisa Hector, Kerry Holford, Tom Jones, Ravi Misra, Xian Deng, Michael Healy, Esther Hong, Iris Zhilin Long, Zhiqiang Shu, Yun Zhong (David Hogg) |
Bank of America Merrill Lynch |
Aspen Mori (NY), Graham Parry (London), Qian Weng, John Aldersley (Dan Lundquist) |
Bryan, Garnier & Co |
Dylan van Haaften, Eric Le Berrigaud, Olga Smolentseva, Victor Floc’h, Jean Jacques Le Fur, (Dominic Wilson) |
CA Cheuvreux |
Marcel Brand, Laurent Flamme, Richard Koch, Oliver Reinberg |
Caja Madrid Bolsa |
Ana Isabel González García |
Carnegie Bank |
Niels Granholm, Philip Lagnetoft, Kristofer Liljeberg-Svensson, Carsten Lonborg Madsen, Henrik Sinding, Lars Topholm |
Cenkos Securities |
Chris Donnellan |
Citigroup |
Liav Abraham (US), Andrew Baum, Alex Glasner, Peter Verdult, Patrick Wood, (David Rawley) |
CM-CIC Securities |
Agnès Blazy, Arsene Guekam |
Commerzbank |
Volker Braun, Daniel Wendorff |
Cowen International |
David Kirkpatrick, Ritu Baral, Ryan Blicker, Ken Cacciatore, Marc Frahm, Joshua Jennings, Chris Lin, Charles Rhyee, Doug Schenkel, Yaron Weber |
Credit Suisse |
Christoph Gretler, Evan Seigerman, Matt Miksic Barbora Blaha, Jo Walton, Matthew Weston, (Phil Gestrin) |
Danske Equities |
Thomas Bowers, Mattias Häggblom, Hans Jeppsson, Martin Parkhøi, Søren Samsøe |
Deutsche Bank |
Emmanuel Papadakis, Rajan Sharma, Justin Bowers, Jack McKibben, Farzana Habib, Katie Kraft, Jeremy Finkelstein, Andrew Vincent |
Degroof Petercam |
Thomas Guillot, Benoit Louage, Chris Keepers |
DnB NOR |
Rune Dahl |
DZ Bank |
Christa Bähr, Elmar Kraus, Thomas Maul, Peter Spengler |
Edison |
John Priestner, Susie Jana, John Savin, Jonas Peciulis, Sean Conroy, Maxim Jacobs, Nathaniel Calloway , Pooya Hemami |
Equinet Institutional Services |
Edouard Aubery |
Equity Development |
Emma Ulker |
Exane BNP Paribas |
Richard Parkes, Alex Evans, Julien Dormois, Hugo Solvet, Nicolas Langlet, Kartik Swaminathan |
fairesearch GmhH & Co |
Martin Schnee |
finnCap |
Mark Brewer, Arshad Ahad, Nik Lysiuk |
Goetz Partners |
Melina Reisenberg, Chris Redhead |
Goldman Sachs |
Krishna-Chaitanya Arikatla, Veronika Dubajova, Divya Harikesh, Keyur Parekh, Graig Suvannavejh, Joanna Tucka, Kira Huppertz |
Handelsbanken Capital Markets |
Klaus Madsen, Björn Olander, Peter Sehested |
Hardman and Co |
Martin Hall, Gregoire Pave |
Helvea |
Daniel Jelovcan, Odile Rundquist, Olav Zilian |
HSBC |
Steve McGarry, Julie Mead, Lucy Acton, Murielle André-Pinard |
ING |
Sjoerd Ummels, David Vagman |
Investec |
Andrew Whitney, Jens Lindqvist, (Brough Ransom) |
Jefferies |
Harry Sephton, Grace Lee, Lucy Codrington, Philippa Gardner, Kit Lee, Ken Rumph, James Vane-Tempest, Peter Welford, Ing Shen Tan, Erin Primdahl, (Jan Scherer) |
JP Morgan Cazenove |
David Adlington, Alex Comer, James Gordon, Richard Vosser, Marjan Daeipour |
KBC Securities |
Sandra Cauwenberghs, Lenny Van Steenhuyse |
Kempen & Co |
Alexander Cogut, Rene Wouters, Suzanne van Voorthuizen, Ingrid Gafanhão, Sebastiaan van der Schoot |
Kepler Capital Markets |
Arsene Gekam, Damien Choplain, David Evans, Maja Pataki, Martin Voegtli, Matthias Maenhaut |
Landesbank Baden-Wuerttemberg |
Timo Kuerschner |
Liberum Capital |
Alistair Campbell, Graham Doyle |
Morgan Stanley |
Alex Gibson, Michael Jungling, Simon Mather, Jenny Leeds, Cailin McGurk |
N+1 Singer |
Chris Glasper, Edward Thomason, Sahill Shan |
Natixis Beatrice |
Philipe Lanone, Jean-Jacques Le Fur |
Nordea Markets |
Klas Pyk |
Nord/LB |
Holger Fechner, Thorsten Strauss |
Numis |
Paul Cuddon, Stefan Hamill, (Ceri Morgan) |
Oddo Securities |
Martial Descoutures, Oussama Denguir |
Panmure Gordon |
Mike Mitchell, Julie Simmonds, (David Cox) |
Pareto Securities |
Finlay Heppenstall, Ulrik Trattner |
Peel Hunt |
Miles Dixon, Anchal Verma, Amy Walker |
Portzamparc Gestion S.A. |
Christophe Dombu |
RBC Capital Markets |
Zoe Karamanoli (maternity), Charles Weston, Jack Reynolds-Clarke |
Redburn |
Simon Baker, Darshan R., Issie Kirby, Charles Pitman, Robert Shore, Ed Ridley-Day |
Rx Securities |
Samir Devani, Joseph Hedden, Michael King, Ross Blair |
Sanford C Bernstein |
Lisa Clive |
Santander |
Rebecca McClellan, Alejandro Conde Fraisolí, Tomasz Krukowski, |
SEB Enskilda |
Lars Hevreng, Henrik Simonsen, Peder Strand |
Shore Capital |
Adam Barker, Tara Raveendran |
Société Générale |
Florent Cespedes, Patrick Jousseaume, Delphine Le Louët, Justin Smith |
Standard & Poors |
Sho Matsubara, Jacob Thrane |
Stifel |
Christian Glennie, Max Herrmann, James Osborne (Erland Sternby) |
Swedbank |
Johan Unnerus |
Trinity Delta |
Lala Gregorek, Franc Gregori |
UBS |
Laura Sutcliffe, Michael Leuchten, Jack Scannell, Sebastien Walker |
Zürcher Kantonalbank |
Michael Nawrath |
Media directory
View our Media Directory
Media directory
BBC Fergus Walsh, Hugh Pym, James Gallagher, Katie Hope, Alex Therrien
Boston Business Journal Lucy Maffei, Don Seiffert, Max Stendahl
Boston Globe Jonathan Saltzman
Boston Herald Jordan Graham
Business Insider Erin Bromley, Lydia Ramsey, Zach Tracer, Marianne Guenot (US), Mia de Graaf (US)
Daily Express Mark Atherton, Becky Fletcher, Giles Sheldrick
Daily Mail Vanessa Chalmers, Jonathan Chadwick, Ethan Ennals, Anna Hodgekiss, Xantha Leatham, Fiona Macrae, Matt Oliver, Rachel Reilly, Alexandra Thompson, Sally Wardle, Victoria Woollaston, Shaun Wooller
Daily Telegraph, Julia Bradshaw, Laura Donnelly, Anne Gulland, Sarah Knapton, Chloe Lambert, Hannah Uttley, Hannah Boland, Jon Yeomans, Louise Moon
Financial Times Clive Cookson, Darren Dodd, Anna Gross, Donato Mancini, Sarah Neville, Gill Plimmer, Barney Thompson (UK); Hannah Kuchler (US)
Forbes Steve Brozak, Bruce Japsen, Leah Rosenbaum
Fortune Sy Mukherjee
Inc. Kimberly Weisul
Mail on Sunday Stephen Adams, Joanne Hart, Eve Simmons, Alex Lawson
Sky News Mark Kleinman, Paul Kelso, Thomas Moore
The Guardian Sarah Boseley, Denis Campbell, Hannah Devlin, Natalie Grover, Julia Kollewe, Linda Geddes
The New York Times Gina Kolata, Andrew Pollack, Alexandra Sifferlin, Sabrina Tavernise, Katie Thomas
The Sunday Times John Collingridge, Andrew Gregory, Jonathan Leake, Sabah Meddings, Lois Rogers, Oliver Shah, Ben Spencer, Jamie Nimmo
The Times Philip Aldrick, Kaya Burgess, James Dean, Richard Fletcher, Tom Howard, Graham Ruddick, Kat Lay, Fiona MacRae, Alex Ralph, Dominic Walsh, James Dean, Callum Jones (US)
The Wall Street Journal Brian Gormley, Daniela Hernandez, Jared Hopkins (US); Robert Lee Hotz, Stefanie Ilgenfritz, Peter Loftus (US); Amy Dockser Marcus, Jonathan Rockoff (US); Denise Roland (Europe, maternity leave);, Joseph Walker, Jeanne Whalen (EU), Anna Wilde Mathews (US), Julie Wernau
The Washington Post Carolyn Johnson
S&P Global Etain Lavelle, Kristen Hallam
APM Health Europe Nick Hudson, Thomas Meek, Natalie Morrison, Eliza Slawther
Associated Press Tom Murphy
Bloomberg Naomi Kresge (Berlin); Albertina Torsoli (Geneva); John Lauerman (Boston), James Paton (London); Drew Armstrong (New York); Marthe Fourcade (Paris); Tim Loh (Munich)
Dow Jones Matteo Castia, Ian Walker, Philip Waller
fastFT Jennifer Thompson
Thomson Reuters Kate Kelland, Paul Sandle
AnimalPharm Joseph Harvey
BioCentury Stephen Hansen (UK); Jonathan Block, Paul Bonanos, Jeff Cranmer, Simone Fishburn, Dave Flores, Virginia Li, Chris Lieu, Lauren Martz, Erin McCallister, Alicia Parker, Susan Schaeffer, Mark Zipkin
BioWorld MedTech Bernard Banga, David Godkin, Larry Haimovitch, Stacy Lawrence, Nuala Moran, Katie Pfaff
BioWorld Shannon Ellis, Michael Fitzhugh, John Fox, Brian Orelli, Randy Osborne, Alfred Romann, Tamra Sami, Cormac Sheridan, Nuala Moran
Endpoints Arsalan Arif, John Carroll, Jason Mast, Amber Tong, Conner Mitchell
Genome Web Ben Butkus, Molika Ashford, Monica Heger, Madeleine Johnson
Fierce Life Sciences Ben Adams, Nick Paul Taylor (UK); Amirah Al Idrus, Michael Gibney, Conor Hale, Carly Helfand, Mark Hollmer, Emily Mullin, Eric Palmer, Tracy Staton, Emily Wasserman (US)
FirstWord Medtech Tina Tan
Healthcare Business International Max Hotopf
HealthInvestor Jonathan Bacon, Vernon Baxter, Sunniva Davies-Rommetveit, Catherine Llewllyn, Jenna Lomax, Ploy Radford
IN VIVO Lucie Ellis (UK); Ben Comer (US)
Investors Chronicle Harriet Clarfelt, Emma Powell, Mark Robinson
Labiotech Clara Rodríguez Fernández, Jonathan Smith
MedCityNews Alaric DeArment
MedNous Victoria English, Karen Finn
Medtech Insight Barnaby Pickering, Jenny Blair, Philip Greenfield (UK); Reed Miller (US)
Nature Biotechnology Lisa Melton
Pharmaphorum Catherine Longworth, Richard Staines, George Underwood
PharmaTimes Selina McKee, Anna Smith
Scrip John Davis, Kevin Grogan, Eleanor Malone, Andrew McConaghie, Alex Shimmings (UK); Joseph Haas, Mandy Jackson, Mary Jo Laffler, Jessica Merrill, Denise Peterson (US); Anju Ghangurde, Ian Haydock (Asia-Pacific)
Shares Magazine Martin Gamble
Sifted Michael Stothard, John Thornhill, Maija Palmer, Amy Lewin, Chris Sisserian, Isabel Woodford, Nicolas Colin, Kitty Knowles (UK), Mimi Billing, Tim Smith (Spain), Tom Turula (Sweden), Marie Mawad (France, maternity leave), Sian Bradley
STAT Mario Aguilar, Adam Feuerstein, Damian Garde, Matthew Herper, Meghana Keshavan, Katie Palmer, Rebecca Robbins, Ed Silverman
The Economist Catherine Brahic, Slavea Chankova, Alice Fulwood, Alok Jha, Natasha Loder
The Pink Sheet Neena Brizmohun, Francesca Bruce, Maureen Kenny, Ian Schofield, Vibha Sharma (UK); Nielsen Hobbs, Sue Sutter (US)
Timmerman Report Luke Timmerman
Vantage Lisa Urquhart, Madeleine Armstrong, Amy Brown, Elizabeth Cairns, Jacob Plieth (UK)
Xconomy Alex Lash, Frank Vinluan, Greg Huang